ARTICLE | Clinical News

CombinatoRx misses periodontitis endpoint

April 8, 2006 1:50 AM UTC

CRXX said CRx-119 in combination with scaling and root planing (SRP) missed the primary endpoint of reduction in C-reactive protein (CRP) levels vs. placebo plus SRP in a Phase IIa trial to treat chronic adult periodontitis. The preliminary data also showed that the combination of prednisolone and amoxapine missed the secondary endpoint of reduction in periodontal pocket depth. CRXX said analysis of another secondary endpoint, a panel of immunomodulatory cytokines, is ongoing. ...